📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Antibody conjugated nanoparticles as a novel form of antibody drug conjugate chemotherapy (2018)

First Author: Johnston M

Attributed to: Tumor priming sequences combined with novel nanoparticle drug carriers for enhanced therapeutic efficacy in pancreatic cancer: a tripartite USA/Northern Ireland/Republic of Ireland consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ddtec.2018.10.003

Publication URI: http://dx.doi.org/10.1016/j.ddtec.2018.10.003

Type: Journal Article/Review

Parent Publication: Drug Discovery Today: Technologies